Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study
Main Authors: | Michael Byrne, Donya Salmasinia, Helen Leather, Christopher R. Cogle, Amy Davis, Jack W. Hsu, Laura Wiggins, Myron N. Chang, Qi An, John R. Wingard, Jan S. Moreb |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-09-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | http://www.la-press.com/tandem-autologous-stem-cell-transplantation-for-multiple-myeloma-patie-article-a4359 |
Similar Items
-
Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study
by: Michael Byrne, et al.
Published: (2014-01-01) -
Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients after Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study
by: Donya Salmasinia, et al.
Published: (2010-01-01) -
Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients
by: Jan S. Moreb, et al.
Published: (2011-01-01) -
Plerixafor in non-Hodgkin’s lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation
by: Jan S. Moreb
Published: (2011-10-01) -
Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
by: Bergantim Rui, et al.
Published: (2012-11-01)